Sterling Capital Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.17K Buy
304
+109
+56% +$1.49K ﹤0.01% 2610
2025
Q1
$2.16K Sell
195
-122
-38% -$1.35K ﹤0.01% 2564
2024
Q4
$3.38K Buy
317
+265
+510% +$2.82K ﹤0.01% 2611
2024
Q3
$660 Buy
+52
New +$660 ﹤0.01% 2746